Clinical Trial Update: Does Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients? [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether maitake mushroom extract can enhance hematopoiesis in patients with myelodysplastic syndromes; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Maitake mushroom extract (Maitake mushroom extract)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2016-05-19